Question 1

What is Iclusig?

Accepted Answer

Iclusig is a targeted therapy known as a kinase inhibitor. It works by blocking the action of specific proteins that signal certain cancer cells to multiply and spread.

By interfering with these signals, the medication helps to manage the growth of abnormal cells associated with specific types of blood cancer.

Question 2

What is Iclusig used for?

Accepted Answer

Iclusig is used to treat chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia .

Question 3

How does Iclusig work?

Accepted Answer

How Iclusig Works

Iclusig is a type of targeted therapy known as a tyrosine kinase inhibitor (TKI). It works by interfering with the specific proteins that tell cancer cells to grow and divide.

In certain types of leukemia, such as chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), a genetic abnormality creates a protein called BCR-ABL. This protein acts like a switch that is permanently stuck in the "on" position, causing the bone marrow to produce too many abnormal white blood cells.

Iclusig works through the following actions:

Blocking Growth Signals: The medication binds to the BCR-ABL protein, preventing it from sending the signals that cause cancer cells to multiply.

Targeting Mutations: Some leukemia cells develop mutations, such as the T315I mutation, which change the shape of the BCR-ABL protein. While many other drugs cannot bind to this altered protein, Iclusig is designed to fit into the protein even when this mutation is present.

Slowing Disease Progression: By inhibiting these proteins, Iclusig helps to reduce the number of cancerous cells and allows the body to produce healthier blood cells.

Question 4

What are the active ingredients in Iclusig?

Accepted Answer

The active ingredient in Iclusig is ponatinib .

Question 5

What are the side effects of Iclusig?

Accepted Answer

Common side effects of Iclusig may include:

Fatigue

Rash

Abdominal pain

and others.

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Iclusig?

Accepted Answer

Iclusig belongs to the tyrosine kinase inhibitor drug class.

Question 7

What is the dosage of Iclusig and how do I take it?

Accepted Answer

How to Take Iclusig

Iclusig is a tablet taken by mouth. It is usually taken once daily. You may take this medication with or without food.

When taking this medication, follow these guidelines:

Swallow the tablet whole. Do not crush, break, or chew it.

Try to take the medicine at the same time each day to maintain a consistent level in your system.

Missed Dose

If you miss a dose of Iclusig, skip the missed dose and take your next dose at the regular time. Do not take two doses at once to make up for a missed one.

Treatment Duration and Changes

Your healthcare provider will determine the appropriate dose for you and may adjust it over time. These changes may be based on how your condition responds to the medication or if you experience certain side effects. Do not change your dose or stop taking the medication without consulting your doctor.

Question 8

Is Iclusig safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Iclusig may cause fetal harm or birth defects if taken during pregnancy. Healthcare providers typically require a pregnancy test before starting treatment for individuals of reproductive potential. It is important to use effective birth control during treatment and for at least 3 weeks after the final dose. If pregnancy occurs while taking this medication, a healthcare professional should be contacted immediately to discuss the potential risks to the fetus.

Breastfeeding

It is not known whether Iclusig passes into human breast milk. Because of the potential for serious adverse reactions in a nursing infant, breastfeeding is not recommended during treatment and for at least 6 days after the last dose.

Fertility

Based on animal studies, Iclusig may impair fertility in females. The long-term effects on human fertility are not fully known. Individuals concerned about their ability to have children should discuss these risks with their healthcare provider before beginning treatment.

Question 9

What forms and strengths does Iclusig come in?

Accepted Answer

Iclusig is available as a film-coated tablet for oral use. It is not available in other forms such as liquids or injections.

Oral Tablet

Patients are advised to swallow the tablets whole. The medication should not be crushed, broken, or chewed before swallowing.

Question 10

What is the FDA approval status of Iclusig?

Accepted Answer

FDA Approval History

Iclusig was first approved by the FDA in December 2012. It is indicated for adults with chronic myeloid leukemia (CML) or Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) who are resistant or intolerant to previous kinase inhibitor therapies, or who have the T315I mutation.

In March 2024, the FDA granted accelerated approval for Iclusig to be used in combination with chemotherapy for adults with newly diagnosed Ph+ ALL. Continued approval for this specific use may depend on verification of clinical benefit in confirmatory trials.

Safety Communications and Restrictions

In 2013, the FDA issued a safety communication and briefly suspended the marketing of Iclusig due to an increased frequency of reports involving life-threatening blood clots and severe narrowing of blood vessels. The drug was later allowed back on the market with additional safety measures, including a revised label and a Risk Evaluation and Mitigation Strategy (REMS).

Boxed Warning

The FDA requires a Boxed Warning for Iclusig, which is the most serious type of warning. This warning covers several critical risks:

Arterial Occlusive Events: Serious and sometimes fatal blood clots in the arteries, which can lead to heart attack, stroke, or decreased blood flow to the limbs.

Venous Thromboembolism: Blood clots in the veins, such as deep vein thrombosis or pulmonary embolism.

Heart Failure: The drug may cause the heart muscle to weaken or fail.

Hepatotoxicity: Potential for severe liver damage, liver failure, or death.

Because of these risks, the FDA requires the Iclusig REMS program to ensure that healthcare providers are informed about the risks and that the drug is used only in patients for whom the benefits outweigh these serious safety concerns.

Question 11

What should I know about Iclusig and cost?

Accepted Answer

Insurance and Prior Authorization

Most insurance plans may cover Iclusig, but it is often classified as a specialty drug. This classification usually requires a process called prior authorization, where a healthcare provider must submit documentation to the insurance company to confirm the medication is medically necessary before coverage is approved.

Specialty Pharmacies

Iclusig is not available at most standard retail pharmacies. It must be obtained through a specialty pharmacy that is authorized to dispense this type of medication. These pharmacies often provide additional services, such as coordinating delivery and helping patients navigate insurance requirements.

Financial Assistance Programs

Because of the high cost of treatment, the manufacturer and various non-profit organizations may offer financial assistance programs. These options may include:

Co-pay cards for patients with commercial insurance

Patient assistance programs for those who are uninsured or underinsured

Patients are encouraged to discuss these options with their doctor or a hospital social worker.

Iclusig

Medication Quick Facts

📋Overview

What It's Used For

How It Works

Side Effects

Warnings & Precautions

Dosage & How to Take

Pregnancy & Breastfeeding

Forms & Strengths

FDA / Regulatory Status

Price Information

FAQ

Found an Error?